sparsentan will decrease the extent or outcome of modafinil by affecting hepatic enzyme CYP2C19 metabolism. Use Warning/Check. Sparsentan (a CYP2C19 inducer) decreases publicity of CYP2C19 substrates and decreases efficacy associated with these substrates. modafinil will lessen the extent or outcome of fruquintinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Avoid https://modafinil77543.prublogger.com/25884514/fascination-about-modafinil